VANCOUVER, BC and TORONTO, July 17, 2024 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company") a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL"), a healthcare technology company focused on AI and data science for preventative care, are jointly pleased to announce the launch of WELL's AI-powered co-pilot for cardiologists exclusively powered by HEALWELL AI, aimed at identifying patients at high risk of cardiovascular disease ("CVD"). This significant expansion of WELL's AI capabilities builds on the success of its second-generation AI-powered physician co-pilot, WELL AI Decision Support ("WAIDS"), developed exclusively in partnership with HEALWELL. This enhancement adds to its existing rare and chronic disease detection abilities and is an extension to the WAIDS offering.
Read more at newswire.caProvided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.